Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation August, 2015.

Recent Releases

Aug 27, 2015
SciClone To Present At Two Investor Conferences On September 10, 2015

Aug 10, 2015
SciClone Reports Second Quarter 2015 Financial Results

View all releases »

Events & Presentations

Sep 10, 2015 at 3:00 PM ET
Rodman & Renshaw Annual Global Investment Conference

Sep 10, 2015 at 11:30 AM ET
22nd Annual NewsMakers in the Biotech Industry

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 7.86
Change: + 0.07
Day High: 7.97
Day Low: 7.76
Volume: 342,600
Delayed at least 20 minutes.
Provided by eSignal.